NCT00002901View on ClinicalTrials.gov

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1996

Conditions
Breast CancerHead and Neck CancerLung CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

docetaxel

Trial Locations (3)

95817

University of California Davis Cancer Center, Sacramento

91010-3000

Cancer Center and Beckman Research Institute, City of Hope, Duarte

90033-0804

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00002901 - Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | Biotech Hunter | Biotech Hunter